3-hydroxyflavone has been researched along with Blood Clot in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, M; Fu, W; Huang, M; Li, J; Liang, C; Liao, X; Liu, Y; Ning, J; Wu, J; Xu, Y; Yuan, C | 1 |
| Jackson, DE; Linden, MD; Mosawy, S; Woodman, OL | 3 |
| Chang, KH; Dong, MS; Hong, CY; Kim, M; Lee, D; Lee, JH; Lee, MY; Na, CS | 1 |
| Gibbins, JM; Hubbard, GP; Lovegrove, JA; Wolffram, S | 1 |
| Hao, YB; Tang, YZ; Wan, BS; Wu, YJ; Zhou, EF | 1 |
1 review(s) available for 3-hydroxyflavone and Blood Clot
| Article | Year |
|---|---|
Identification of Antithrombotic Natural Products Targeting the Major Substrate Binding Pocket of Protein Disulfide Isomerase.
Topics: Animals; Binding Sites; Biological Products; Fibrinolytic Agents; Mice; Molecular Docking Simulation; Protein Binding; Protein Disulfide-Isomerases; Thrombosis | 2022 |
1 trial(s) available for 3-hydroxyflavone and Blood Clot
| Article | Year |
|---|---|
Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans.
Topics: Blood Platelets; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Collagen; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Female; Flavonols; Glucosides; Humans; Immunoblotting; Male; Phosphorylation; Platelet Activation; Platelet Aggregation; Quercetin; Signal Transduction; Thrombosis; Time Factors; Tyrosine | 2004 |
5 other study(ies) available for 3-hydroxyflavone and Blood Clot
| Article | Year |
|---|---|
The flavonols quercetin and 3',4'-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes.
Topics: Animals; Antioxidants; Blood Platelets; Carotid Arteries; Carotid Artery Injuries; Chlorides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Exocytosis; Ferric Compounds; Flavonols; Laser-Doppler Flowmetry; Mice; Mice, Inbred C57BL; Platelet Activation; Platelet Aggregation; Quercetin; Thrombosis | 2014 |
Antiplatelet effects of Rhus verniciflua stokes heartwood and its active constituents--fisetin, butein, and sulfuretin--in rats.
Topics: Animals; Benzofurans; Blood Platelets; Cardiovascular Diseases; Chalcones; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Flavonols; Male; p38 Mitogen-Activated Protein Kinases; Phytotherapy; Plant Extracts; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats, Sprague-Dawley; Rhus; Thrombosis; Wood | 2015 |
Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.
Topics: Animals; Antioxidants; Disease Models, Animal; Exocytosis; Female; Flavonols; Male; Mice; Platelet Aggregation; Quercetin; Thrombosis; Time Factors | 2013 |
Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Arteries; Blood Platelets; Cytoplasmic Granules; Exocytosis; Fibrinogen; Flavonols; Humans; Mice; P-Selectin; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Quercetin; Quinacrine; Regional Blood Flow; Thrombosis | 2013 |
[Effects of 4'-methyl-7-(2-hydroxy-3-isopropylaminopropoxy)-flavone hydrochloride on experimental thrombus formation in rats and rabbits].
Topics: Animals; Carotid Artery Thrombosis; Fibrinolytic Agents; Flavonoids; Flavonols; Male; Rabbits; Rats; Thrombosis | 1986 |